Direkt zum Inhalt

GUMBOHATCH® INSIGHTS #5

Posts
Geflügel

SMART VACCINATION against GUMBORO disease: GUMBOHATCH®, Hipraject® & HIPRAlink® Vaccination



At the present time, the SMART VACCINATION concept is being revitalized with the launch of a new vaccine, GUMBOHATCH®, an innovative immune complex vaccine against Gumboro disease with unique IgY from eggs and specific controls to ensure the complete coating of the IBDV virus.

gumbohatch-hipra-vaccine

For GUMBOHATCH®, HIPRA has specifically developed a device for the subcutaneous administration of 0.2 ml with a high level of quality and precision throughout the entire process: Hipraject®.

Furthermore, HIPRAlink® Vaccination, the third element of the SMART VACCINATION concept, has also been adapted to record all the vaccination data generated by Hipraject®, providing traceability and control for the entire vaccination process. It also helps veterinarians and hatchery managers to manage, analyse and certify their own vaccination activity:

· Management: Veterinarians or Hatchery Managers can easily check the GUMBOHATCH® vaccination data for each session: date and time, number of doses, number of chicks, information on the product, speed of the session, farm etc. The vaccination data are recorded automatically and are objective, transparent and reliable.

· Analysis: HIPRAlink® Vaccination can generate vaccination reports for GUMBOHATCH® to facilitate the analysis of data. In addition, the App shows statistical data in graph form (e.g. trend in the number of doses).

· Traceability: The user is able to generate traceability reports for GUMBOHATCH® that can be shared directly with the recipient company via HIPRAlink® Vaccination.

traceability-report

Thanks to the concept of SMART VACCINATION and Hipraject®, HIPRA ensures the optimal subcutaneous administration of its new immune complex vaccine against Gumboro disease, GUMBOHATCH®.

 


© Laboratorios Hipra, S.A. All Rights Reserved.


No part of these contents may be reproduced, copied, modified or adapted, without the prior written consent of HIPRA